Robert H. Carnahan

8.6k total citations · 3 hit papers
54 papers, 2.6k citations indexed

About

Robert H. Carnahan is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Robert H. Carnahan has authored 54 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Infectious Diseases, 18 papers in Molecular Biology and 13 papers in Epidemiology. Recurrent topics in Robert H. Carnahan's work include SARS-CoV-2 and COVID-19 Research (15 papers), Viral Infections and Vectors (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert H. Carnahan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (15 papers), Viral Infections and Vectors (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). Robert H. Carnahan collaborates with scholars based in United States, Germany and Japan. Robert H. Carnahan's co-authors include Albert B. Reynolds, Kathleen L. Gould, James E. Crowe, Rachel E. Sutton, Seth J. Zost, Nichole A. Lobdell, Michael A. Davis, Pavlo Gilchuk, Gregg Wildenberg and Michael R. Dohn and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Robert H. Carnahan

52 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Pavlo Gilchuk, Seth J. Zost et al. Cell Host & Microbe profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Pavlo Gilchuk et al. Cell profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers

Robert H. Carnahan

IMMUN

RNMI

Ursula Dietrich Germany

Martin Vey Germany

Qiaozhen Ye United States

Brendon J. Hanson Singapore

Stephen Griffin United Kingdom

Hans-Heinrich Hoffmann United States

J. J. M. Onderwater Netherlands

Shirit Einav United States

Alan Rein United States

Andrew W. Tai United States

Ursula Dietrich Germany

Robert H. Carnahan

1.1k ×0.9

1.8k ×1.5

166 ×0.4

524 ×1.7

IMMUN

379 ×1.5

RNMI

Citations per year, relative to Robert H. Carnahan Robert H. Carnahan (= 1×) peers Ursula Dietrich

Countries citing papers authored by Robert H. Carnahan

Since Specialization

Citations

This map shows the geographic impact of Robert H. Carnahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Carnahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Carnahan more than expected).

Fields of papers citing papers by Robert H. Carnahan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Carnahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Carnahan. The network helps show where Robert H. Carnahan may publish in the future.

Co-authorship network of co-authors of Robert H. Carnahan

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Carnahan. A scholar is included among the top collaborators of Robert H. Carnahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Carnahan. Robert H. Carnahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoder, Sandra, Rachel S. Nargi, Nurgun Kose, et al.. (2023). Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. Journal of the Pediatric Infectious Diseases Society. 12(5). 298–305. 1 indexed citations

Wen, Xiaolin, Naveenchandra Suryadevara, Nurgun Kose, et al.. (2023). Potent cross-neutralization of respiratory syncytial virus and human metapneumovirus through a structurally conserved antibody recognition mode. Cell Host & Microbe. 31(8). 1288–1300.e6. 10 indexed citations

Shiakolas, Andrea R., Kevin J. Kramer, Nicole V. Johnson, et al.. (2022). Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nature Biotechnology. 40(8). 1270–1275. 27 indexed citations

Raju, Nagarajan, Xiaoyan Zhan, Subash C. Das, et al.. (2022). Neutralization fingerprinting technology for characterizing polyclonal antibody responses to dengue vaccines. Cell Reports. 41(11). 111807–111807. 1 indexed citations

Kramer, Kevin J., Erin M. Wilfong, Kelsey Voss, et al.. (2022). Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine. Nature Communications. 13(1). 3466–3466. 29 indexed citations

Kafai, Natasha M., Lauren E. Williamson, Elad Binshtein, et al.. (2022). Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge. The Journal of Experimental Medicine. 219(4). 16 indexed citations

Winkler, Emma S., Pavlo Gilchuk, Jinsheng Yu, et al.. (2021). Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 184(7). 1804–1820.e16. 183 indexed citations breakdown →

Bozhanova, Nina G., Amandeep K. Sangha, Alexander M. Sevy, et al.. (2020). Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions. Proceedings of the National Academy of Sciences. 117(49). 31142–31148. 9 indexed citations

Fox, Julie M., Nurgun Kose, Arthur S. Kim, et al.. (2020). Human monoclonal antibodies against Ross River virus target epitopes within the E2 protein and protect against disease. PLoS Pathogens. 16(5). e1008517–e1008517. 20 indexed citations

10.

Williamson, Lauren E., Theron Gilliland, Pramod Kumar Yadav, et al.. (2020). Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection. Cell. 183(7). 1884–1900.e23. 27 indexed citations

11.

Kurley, Sarah J., Verena Tischler, Brian Bierie, et al.. (2020). A Requirement for p120-catenin in the metastasis of invasive ductal breast cancer. Journal of Cell Science. 134(6). 5 indexed citations

12.

Miller, Andrew S., Julie M. Fox, Nurgun Kose, et al.. (2020). Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site. Cell Host & Microbe. 28(5). 699–711.e7. 45 indexed citations

13.

Erasmus, Jesse H., Jacob Archer, Amit P. Khandhar, et al.. (2020). Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection. Molecular Therapy — Methods & Clinical Development. 18. 402–414. 83 indexed citations

14.

Knudtson, Kevin L., Robert H. Carnahan, Nancy C. Fisher, et al.. (2019). Survey on Scientific Shared Resource Rigor and Reproducibility. Journal of Biomolecular Techniques JBT. 30(3). 36–44. 15 indexed citations

15.

Short, Sarah P., Jumpei Kondo, Haruna Takeda, et al.. (2017). p120-Catenin is an obligate haploinsufficient tumor suppressor in intestinal neoplasia. Journal of Clinical Investigation. 127(12). 4462–4476. 16 indexed citations

16.

Shaver, Ciara M., Nathan D. Putz, Jennifer K. Clune, et al.. (2015). Regulation of Alveolar Procoagulant Activity and Permeability in Direct Acute Lung Injury by Lung Epithelial Tissue Factor. American Journal of Respiratory Cell and Molecular Biology. 53(5). 719–727. 37 indexed citations

17.

Barrett, Caitlyn W., J. Joshua Smith, Nicholas O. Markham, et al.. (2012). Kaiso Directs the Transcriptional Corepressor MTG16 to the Kaiso Binding Site in Target Promoters. PLoS ONE. 7(12). e51205–e51205. 20 indexed citations

18.

Xia, Xiaobo, et al.. (2006). p120 serine and threonine phosphorylation is controlled by multiple ligand–receptor pathways but not cadherin ligation. Experimental Cell Research. 312(17). 3336–3348. 22 indexed citations

19.

Wildenberg, Gregg, Michael R. Dohn, Robert H. Carnahan, et al.. (2006). p120-Catenin and p190RhoGAP Regulate Cell-Cell Adhesion by Coordinating Antagonism between Rac and Rho. Cell. 127(5). 1027–1039. 332 indexed citations

20.

Carnahan, Robert H. & Kathleen L. Gould. (2003). The PCH family protein, Cdc15p, recruits two F-actin nucleation pathways to coordinate cytokinetic actin ring formation in Schizosaccharomyces pombe. The Journal of Cell Biology. 162(5). 851–862. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact